Market Pulse
Daily · Oct 13, 2026 · data.go.kr + ECOS
KOSPI
6,035.35
-348.89 (-5.46%)
KOSDAQ
837.03
-12.16 (-1.43%)
KOSPI 200
942.07
-62.85 (-6.25%)
USD/KRW
1,345.10
326030KOSPI·May 27, 2026
Initiating Coverage: Xcopri’s Run; Securing New Growth Engines is Next
KB Securities published a company analysis report on SK biopharmaceuticals Co., Ltd. (326030) titled "Initiating Coverage: Xcopri’s Run; Securing New Growth Engines is Next".
Summary
Covers SK biopharmaceuticals Co., Ltd. (326030).
Covered stock
More on 326030
Two concerns addressed; focus now turns to RISE3 dataMirae Asset Securities · Aug 27, 2026Solid earnings; adding a second product could unlock further upsideMirae Asset Securities · Aug 07, 2026Strong 1Q26 earnings outlook vs. full-year cost pressuresMirae Asset Securities · Feb 09, 2026Strong 2Q25 results ease concernsMirae Asset Securities · Aug 06, 2025Concerns are overblownMirae Asset Securities · May 13, 2025Leading the wayMirae Asset Securities · Feb 07, 2025